SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[Skystar Bio-Pharmaceutical Awarded High Technology Enterprise Certificate Preferentialome Tax Rate Extended through 2011 XI'AN, CHINA, September 2, 2009ystar Bio-Pharmaceuticalmpany High Technology Enterprise Certificates are awarded to qualified enterprises that meet the following criteria: developingre intellectual property rights, receiving over 60% of their annual revenues from high-technology products/services, and perform highly technical research and development.ystar initially]

By | 2016-02-05T05:09:35+00:00 September 2nd, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Skystar Bio-Pharmaceutical Awarded High Technology Enterprise Certificate Preferentialome

[Skystar Bio-Pharmaceutical Awarded High Technology Enterprise Certificate Preferentialome Tax Rate Extended through 2011 XI'AN, CHINA, September 2, 2009ystar Bio-Pharmaceuticalmpany High Technology Enterprise Certificates are awarded to qualified enterprises that meet the following criteria: developingre intellectual property rights, receiving over 60% of their annual revenues from high-technology products/services, and perform highly technical research and development.ystar initially]

By | 2016-02-05T05:10:05+00:00 September 2nd, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

HGSH [CHINA HGS REAL ESTATE] 8-K: Page Consolidated Balance Sheets as of June 30,

[Page Consolidated Balance Sheets as of June 30, 2009 (Unaudited) and December 31, 2008 52 Consolidated Statements of Operation for the Six Months ended June 30, 2009 and 2008 (Unaudited) 53 Consolidated Statements of Changes in Shareholders' Equity for the Six Months ended June 30, 2009 and 2008 (Unaudited) 54 Consolidated Statements of Cash Flows for the Six Months ended] [Page 75 Balance Sheets at December 31, 2008 and 2007 76 Statements of Income for the Years ended December 31, 2008 and 2007 77 Statements of Shareholders' Equity for the Years ended December 31, 2008 and 2007 78 Statements of Cash Flows for the Years ended December 31, 2008 and 2007 79 Notes to Financial Statements 80-98 74 To the] [Page Introduction to Unaudited Pro Forma Condensed Consolidated Financial Statements 100 Pro Forma Condensed Consolidated Balance Sheets as of June 30, 2009 (Unaudited) 101 Pro Forma Condensed Consolidated Statement of Operations for the Year Ended September 30, 2008 (Unaudited) 102 Pro Forma Condensed Consolidated Statement of Operations for the Nine Months Ended June 30, 2009 (Unaudited) 103 Notes to Condensed] [EXPLANATORY NOTE This current report is being filed in connection with a series of transactions consummated by the Company and certain related events and actions taken by the Company. This current report responds to the following items on Form 8-K: Item 1.01 Entry into a Material Definitive Agreement Item 2.01 Completion of Acquisition of Assets]

By | 2016-03-29T07:21:16+00:00 August 31st, 2009|Categories: Chinese Stocks, HGSH, Webplus ver|Tags: , , , , , |0 Comments

HGSH [CHINA HGS REAL ESTATE] 8-K: (Original Filing)

[Page Consolidated Balance Sheets as of June 30, 2009 (Unaudited) and December 31, 2008 52 Consolidated Statements of Operation for the Six Months ended June 30, 2009 and 2008 (Unaudited) 53 Consolidated Statements of Changes in Shareholders' Equity for the Six Months ended June 30, 2009 and 2008 (Unaudited) 54 Consolidated Statements of Cash Flows for the Six Months ended] [Page 75 Balance Sheets at December 31, 2008 and 2007 76 Statements of Income for the Years ended December 31, 2008 and 2007 77 Statements of Shareholders' Equity for the Years ended December 31, 2008 and 2007 78 Statements of Cash Flows for the Years ended December 31, 2008 and 2007 79 Notes to Financial Statements 80-98 74 To the] [Page Introduction to Unaudited Pro Forma Condensed Consolidated Financial Statements 100 Pro Forma Condensed Consolidated Balance Sheets as of June 30, 2009 (Unaudited) 101 Pro Forma Condensed Consolidated Statement of Operations for the Year Ended September 30, 2008 (Unaudited) 102 Pro Forma Condensed Consolidated Statement of Operations for the Nine Months Ended June 30, 2009 (Unaudited) 103 Notes to Condensed] [EXPLANATORY NOTE This current report is being filed in connection with a series of transactions consummated by the Company and certain related events and actions taken by the Company. This current report responds to the following items on Form 8-K: Item 1.01 Entry into a Material Definitive Agreement Item 2.01 Completion of Acquisition of Assets]

By | 2016-03-29T07:20:30+00:00 August 31st, 2009|Categories: Chinese Stocks, HGSH, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[CHINA PHARMA HOLDINGS, INC. CHARTER OF THE NOMINATING AND COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I. Purpose The Nominating and Compensation Committee (the “Committee”) of the Board of Directors of China Pharma Holdings, Inc. (the “Company”) is established to: • Formulate goals and objectives relating to compensation payable to the]

By | 2016-03-03T21:59:01+00:00 August 28th, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: CHINA PHARMA HOLDINGS, INC. CHARTER OF THE NOMINATING

[CHINA PHARMA HOLDINGS, INC. CHARTER OF THE NOMINATING AND COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I. Purpose The Nominating and Compensation Committee (the “Committee”) of the Board of Directors of China Pharma Holdings, Inc. (the “Company”) is established to: • Formulate goals and objectives relating to compensation payable to the]

By | 2016-03-03T22:00:47+00:00 August 28th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[CHINA PHARMAS, CHARTER OF THE NOMINATING ANDMPENSATIONMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I.Purpose The Nominating andmpensationmmittee (themmittee) of the Board of Directors of China Pharmas, (thempany) is established to: Formulate goals and objectives relating tompensation payable to thempanys Chief Executive Officer (CEO) and, innsultation with the]

By | 2016-02-08T00:20:36+00:00 August 28th, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: CHINA PHARMAS, CHARTER OF THE NOMINATING ANDMPENSATIONMMITTEE OF

[CHINA PHARMAS, CHARTER OF THE NOMINATING ANDMPENSATIONMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I.Purpose The Nominating andmpensationmmittee (themmittee) of the Board of Directors of China Pharmas, (thempany) is established to: Formulate goals and objectives relating tompensation payable to thempanys Chief Executive Officer (CEO) and, innsultation with the]

By | 2016-02-08T00:21:08+00:00 August 28th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

NFEC [NF Energy Saving] 8-K: (Original Filing)

[NF Energy Saving Corporation Announces 1-for-3 Reverse Stock Split and Ticker Symbol Change to NFEC Company Positions for Upgraded Listing SHENYANG, China, August 25, 2009 In conjunction with the new symbol, the company will complete a 1-for-3 reverse stock split of its common stock. Prior to the market open on August 26, 2009, shareholders will receive one share of NFEC]

By | 2016-03-04T19:21:53+00:00 August 26th, 2009|Categories: Chinese Stocks, NFEC, SEC Original|Tags: , , , , , |0 Comments

NFEC [NF Energy Saving] 8-K: NF Energy Saving Corporation Announces 1-for-3 Reverse Stock

[NF Energy Saving Corporation Announces 1-for-3 Reverse Stock Split and Ticker Symbol Change to NFEC Company Positions for Upgraded Listing SHENYANG, China, August 25, 2009 In conjunction with the new symbol, the company will complete a 1-for-3 reverse stock split of its common stock. Prior to the market open on August 26, 2009, shareholders will receive one share of NFEC]

By | 2016-03-04T19:23:16+00:00 August 26th, 2009|Categories: Chinese Stocks, NFEC, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar